Loading
Life sciences · Journal article
Human Vaccines & Immunotherapeutics · October 2, 2026
No summary has been generated for this record yet. What follows is drawn from its source metadata only.
Journal article.
No findings were extractable from the material analysed.
Safety was not reported in the material analysed. Check the source before drawing any conclusion about harm.
The source did not state who this applies to in practice.
Graded across the dimensions that decide whether you should act, each from what the source actually supports. There is no single score, and where a dimension was not assessed it says so.
This record has not been graded across any dimension yet. Treat the label above as provisional and read the source.
What is missing. This record has no bottom line, key findings, reported figures, evidence dimensions. That is a gap in the analysis, not a judgement about the study.
Nanotechnology has transformed vaccine development by engineering nanovaccines that offer precise control over antigen performance, immune modulation and targeted delivery. These platforms influence physicochemical properties size, charge, and ligand expression to direct antigen trafficking, co-deliver adjuvants and antigen-presenting cells, stimulating potent and robust adaptive immune responses. This review discusses the development of nanovaccines for prophylactic vaccines which induce antibody and memory B-cell responses and therapeutic cancer vaccines, which overcome tolerance and immunosuppression to activate CD8+ T cells with particular emphasis on lipid nanoparticles (LNPs), polymeric NPs, inorganic-core NPs, virus-like particles (VLP) and mechanisms by which each platform exploits physicochemical properties to enhance the antigen encapsulation, adjuvant incorporation, lymphatic transferring, quality and quantity of adaptive immune responses. We reviewed the clinical and preclinical developments of these nanovaccine platforms in cancer and infectious disease immunotherapy, including major successes and new opportunities that will shape the future of vaccines for prevention and treatment.